Testing effectiveness (Phase 2)Active Not RecruitingNCT07651475What this trial is testingStudy of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)Who this might be right forR/R AML Liping Dou 32
Large-scale testing (Phase 3)Study completedNCT01147939What this trial is testingStudy of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid Leukemia (AML) Clavis Pharma 381
Testing effectiveness (Phase 2)Ended earlyNCT03176277What this trial is testingONO-7475 in Patients With Acute LeukemiasWho this might be right forAcute LeukemiaMyelodysplastic Syndromes Ono Pharmaceutical Co., Ltd. 42
Very early researchWithdrawnNCT07338357What this trial is testingClinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AMLWho this might be right forAML (Acute Myeloid Leukemia)CAR-T First Affiliated Hospital of Guangxi Medical University
Testing effectiveness (Phase 2)Ended earlyNCT00112723What this trial is testingFlavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729What this trial is testingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more Fred Hutchinson Cancer Center 53
Early research (Phase 1)Ended earlyNCT04250051What this trial is testingIvosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more Northwestern University 2
Early research (Phase 1)Looking for participantsNCT05188170What this trial is testingNiclosamide in Pediatric Patients With Relapsed and Refractory AMLWho this might be right forAcute Myeloid Leukemia (AML) Stanford University 16
Testing effectiveness (Phase 2)UnknownNCT04913922What this trial is testingRelatlimab With Nivolumab and 5-Azacytidine for the Treatment of AMLWho this might be right forAcute Myeloid Leukemia Ludwig-Maximilians - University of Munich 30
Testing effectiveness (Phase 2)Looking for participantsNCT05092451What this trial is testingPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesWho this might be right forB-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01589302What this trial is testingPCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic LeukemiaWho this might be right forProlymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory/Relapsed Chronic Lymphocytic Leukemia Kami Maddocks, MD 154
Large-scale testing (Phase 3)Looking for participantsNCT06943872What this trial is testingInvestigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeOne Medicines 630
Testing effectiveness (Phase 2)Looking for participantsNCT06644183What this trial is testingRoginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemiaRelapsed LeukemiaChronic Lymphocytic Leukemia+2 more Jennifer R. Brown, MD, PhD 64
Early research (Phase 1)Ended earlyNCT02588456What this trial is testingPilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic LeukemiaWho this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia University of Pennsylvania 5
Testing effectiveness (Phase 2)Ended earlyNCT00792831What this trial is testingPhase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Italfarmaco 3
Large-scale testing (Phase 3)UnknownNCT03391739What this trial is testingCART-19 Cells For R/R B-ALLWho this might be right forRelapsed/Refractory B-cell ALL Fujian Medical University 20
Not applicableLooking for participantsNCT06450067What this trial is testingInaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic LeukemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia Juventas Cell Therapy Ltd. 200
Not applicableLooking for participantsNCT06355739What this trial is testingCD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+Who this might be right forB Lymphocytic LeukemiaB Lymphoblastic Lymphoma Zhu Xiaofan 60
Early research (Phase 1)Study completedNCT00357305What this trial is testingVorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more National Cancer Institute (NCI) 25
Early research (Phase 1)Ended earlyNCT03601819What this trial is testingPacritinib in Relapsed/Refractory Lymphoproliferative DisordersWho this might be right forLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more University of Michigan Rogel Cancer Center 4